Regelgeving en recht · 18-1-20051 min lezen
Solicitation of Comments on Dispensing of Controlled Substances for the Treatment of Pain
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
On November 16, 2004, DEA published in the Federal Register an Interim Policy Statement on the dispensing of controlled substances for the treatment of pain. The Interim Policy Statement stated that DEA would address the subject in greater detail in a future Federal Register document, taking into consideration the views of the medical community. DEA is hereby seeking comments from physicians and other interested members of the public as to what areas of the law relating to the dispensing of controlled substances for the treatment of pain they would like DEA to address in the upcoming Federal Register document.